Syngene International has announced a significant revision to its financial outlook for FY26, projecting a decline of 2-3% compared to its previous forecast of mid-single digit growth. This updated guidance represents a notable shift in the company's expectations for the upcoming fiscal year.

Revised Financial Outlook

The pharmaceutical services company has adjusted its growth projections substantially, moving from an anticipated positive growth trajectory to expecting a contraction in business performance. The following table illustrates the change in outlook:

Impact on Business Expectations

This revision in guidance reflects a significant change in the company's assessment of market conditions and business prospects for FY26. The shift from expecting mid-single digit growth to anticipating a 2-3% decline indicates that Syngene International is now taking a more conservative approach to its financial projections.

The updated forecast suggests that the company is adjusting its expectations based on current market dynamics and operational considerations that have emerged since the previous guidance was issued.

Syngene International Limited has paid regulatory fines totaling ₹23,600 to stock exchanges for non-compliance with SEBI listing regulations regarding committee composition. The biotechnology services company faced penalties for violating requirements related to its Nomination & Remuneration Committee structure during the quarter ended September 30, 2025.

Regulatory Violation Details

Both NSE and BSE issued notices to Syngene International on November 28, 2025, citing non-compliance with Regulation 19(1) and 19(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The violation pertained to the constitution of the nomination and remuneration committee.

The exchanges imposed a daily penalty of ₹2,000 for the 10-day period of non-compliance, resulting in a base fine of ₹20,000. Including GST at 18%, the total penalty amounted to ₹23,600.

Board Response and Compliance

Syngene International's Board of Directors addressed the regulatory violation in their meeting held on January 22, 2026. The Board took note of the matter and advised ensuring compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 in letter and spirit. The company confirmed that the fine has been duly paid to the respective stock exchanges and has ensured compliance with the relevant regulations.

Exchange Notices and Consequences

The stock exchanges had warned of severe consequences for non-payment within the stipulated 15-day period, including:

• Freezing of entire shareholding of promoters in the company
• Freezing of all other securities held in promoters' demat accounts
• Potential shifting to 'Trade for Trade' basis or Z Category for consecutive defaults

Company's Assurance

Syngene International emphasized that it has always endeavored to comply with applicable regulations and has undertaken necessary steps to strengthen its processes to avoid such inadvertent delays in future. The company secretary and compliance officer, Chethan Yogesh, signed the disclosure on January 22, 2026, confirming the Board's acknowledgment and the fine payment.

The regulatory notices were issued under SEBI's Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, which specifies the Standard Operating Procedure for imposing fines and suspension of trading for non-compliance with listing regulations.